Nomination committee in Oncopeptides established
STOCKHOLM — October 21, 2020 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), today announced that the composition of the Nomination Committee for the Annual General Meeting 2021 has been established. The Nomination Committee consists of the following persons who together represent approximately 34 percent of the number of shares and votes in the company, based on the shareholder information by the end of September;· Staffan Lindstrand, appointed by HealthCap VI L.P. · Patrik Sobocki, appointed by Stiftelsen Industrifonden · Ulrik Grönvall, appointed by Swedbank Robur Fonder ·